Company Filing History:
Years Active: 2018
Title: Paul Sohn: Innovator in Obesity and Metabolic Syndrome Treatment
Introduction
Paul Sohn is a notable inventor based in Las Vegas, NV (US). He has made significant contributions to the field of medical research, particularly in the treatment of obesity, metabolic syndrome, and atherosclerosis. His innovative approach focuses on the inhibition of specific enzymes to combat these related diseases.
Latest Patents
Paul Sohn holds a patent for a method titled "Method for selectively inhibiting ACAT1 in the treatment of obesity, metabolic syndrome, and atherosclerosis." This invention presents methods for preventing and treating diet-induced obesity, metabolic syndrome, and atherosclerosis by inhibiting Acyl-CoA:Cholesterol Acyltransferase 1 (ACAT1) activity or expression in myeloid cells. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Paul is affiliated with Dartmouth College, where he continues to engage in research and development in his field. His work is characterized by a strong focus on innovative solutions to pressing health issues.
Collaborations
He has collaborated with notable colleagues, including Ta-Yuan Chang and Catherine C Y Chang, to further enhance the impact of his research and inventions.
Conclusion
Paul Sohn's contributions to the field of medical research highlight his dedication to finding effective treatments for obesity and related conditions. His innovative methods and collaborations with esteemed colleagues underscore the importance of teamwork in advancing healthcare solutions.